Richard Grosse

1.4k total citations
67 papers, 1.2k citations indexed

About

Richard Grosse is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Richard Grosse has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 19 papers in Genetics and 8 papers in Oncology. Recurrent topics in Richard Grosse's work include Animal Genetics and Reproduction (12 papers), Cancer Cells and Metastasis (6 papers) and Digestive system and related health (6 papers). Richard Grosse is often cited by papers focused on Animal Genetics and Reproduction (12 papers), Cancer Cells and Metastasis (6 papers) and Digestive system and related health (6 papers). Richard Grosse collaborates with scholars based in Germany, United States and Canada. Richard Grosse's co-authors include E. Spitzer, K. Repke, Thomas Müller, Klaus Eckert, Valdur Saks, W Zschiesche, Armin Kurtz, J. Schöneich, P. Langen and H. Schmidt and has published in prestigious journals such as The Journal of Cell Biology, Biochemistry and Cancer Research.

In The Last Decade

Richard Grosse

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Grosse Germany 20 715 278 210 108 102 67 1.2k
Fanny Norris Denmark 14 789 1.1× 121 0.4× 174 0.8× 156 1.4× 67 0.7× 17 1.5k
Miho Takahashi Japan 22 629 0.9× 185 0.7× 107 0.5× 79 0.7× 57 0.6× 92 1.5k
Douglas W. Morgan United States 24 683 1.0× 273 1.0× 93 0.4× 109 1.0× 212 2.1× 53 1.4k
Giovanni Alfredo Puca Italy 20 923 1.3× 207 0.7× 602 2.9× 67 0.6× 92 0.9× 41 1.6k
Roy A. Johanson United States 17 793 1.1× 183 0.7× 70 0.3× 94 0.9× 89 0.9× 30 1.1k
Jianming Lu United States 14 898 1.3× 399 1.4× 177 0.8× 158 1.5× 97 1.0× 27 1.6k
Howard C. Haspel United States 20 1.3k 1.8× 193 0.7× 143 0.7× 111 1.0× 246 2.4× 33 1.8k
John L. Krstenansky United States 26 1.1k 1.6× 374 1.3× 165 0.8× 504 4.7× 135 1.3× 73 1.8k
Paolo Laccetti Italy 22 663 0.9× 338 1.2× 95 0.5× 104 1.0× 86 0.8× 51 1.4k
K. Nagano Japan 17 756 1.1× 149 0.5× 93 0.4× 74 0.7× 53 0.5× 48 1.2k

Countries citing papers authored by Richard Grosse

Since Specialization
Citations

This map shows the geographic impact of Richard Grosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Grosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Grosse more than expected).

Fields of papers citing papers by Richard Grosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Grosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Grosse. The network helps show where Richard Grosse may publish in the future.

Co-authorship network of co-authors of Richard Grosse

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Grosse. A scholar is included among the top collaborators of Richard Grosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Grosse. Richard Grosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spitzer, E., et al.. (2002). Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient. European Respiratory Journal. 19(2). 374–376. 2 indexed citations
2.
Spitzer, E., et al.. (2000). Detection ofBRCA1 andBRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. International Journal of Cancer. 85(4). 474–481. 18 indexed citations
3.
Li, Minglin, E. Spitzer, W Zschiesche, et al.. (1995). Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland. Journal of Cellular Physiology. 164(1). 1–8. 17 indexed citations
4.
Spitzer, E., W Zschiesche, Bert Binas, Richard Grosse, & Bettina Erdmann. (1995). EGF and TGFα modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: Possible role of the arachidonic acid pathway. Journal of Cellular Biochemistry. 57(3). 495–508. 14 indexed citations
5.
Kozak, Christine A., et al.. (1994). Cloning and characterization of the mouse gene encoding mammary-derived growth inhibitor/heart-fatty acid-binding protein. Gene. 147(2). 237–242. 56 indexed citations
6.
Zavizion, Boris, I. Politis, R.C. Gorewit, et al.. (1993). Effect of Mammary-Derived Growth Inhibitor on Proliferation of MAC-T Bovine Mammary Epithelial Cells. Journal of Dairy Science. 76(12). 3721–3726. 19 indexed citations
7.
Binas, Bert, E. Spitzer, W Zschiesche, et al.. (1992). Hormonal induction of functional differentiation and mammary-derived growth inhibitor expression in cultured mouse mammary gland explants. In Vitro Cellular & Developmental Biology - Animal. 28(9-10). 625–634. 41 indexed citations
8.
Brandt, Ralf & Richard Grosse. (1992). Purification of a mammary-derived growth inhibitor (MDGI) related polypedptide expressed during pregnancy. Biochemical and Biophysical Research Communications. 189(1). 406–413. 5 indexed citations
9.
Politis, I., R.C. Gorewit, Thomas Müller, & Richard Grosse. (1992). Mammary-derived growth inhibitor in lactation and involution. Domestic Animal Endocrinology. 9(1). 89–94. 10 indexed citations
10.
Vogel, F. Stephen, Thomas Mueller, & Richard Grosse. (1992). 4.5 Is the mammary-derived growth inhibitor (MDGI) related 70 kD antigen, identified in nuclei, a nuclear receptor for MDGI or its hydrophobic ligands?. Progress in Histochemistry and Cytochemistry. 26(1-4). 159–163. 1 indexed citations
11.
Politis, I., R.C. Gorewit, Thomas Müller, & Richard Grosse. (1992). Mammary-Derived Growth Inhibitor Protein and Messenger Ribonucleic Acid Concentrations in Different Physiological States of the Gland. Journal of Dairy Science. 75(6). 1423–1429. 6 indexed citations
12.
Wallukat, Gerd, et al.. (1991). Modulation of the beta-adrenergic-response in cultured rat heart cells. Molecular and Cellular Biochemistry. 102(1). 49–60. 15 indexed citations
13.
Spener, Friedrich, et al.. (1990). Characteristics of fatty acid-binding proteins and their relation to mammary-derived growth inhibitor. Molecular and Cellular Biochemistry. 98(1-2). 57–68. 48 indexed citations
14.
Wobus, Anna M., W Zschiesche, & Richard Grosse. (1990). Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells. Virchows Archiv B Cell Pathology Including Molecular Pathology. 59(1). 339–342. 12 indexed citations
15.
Spitzer, E., et al.. (1989). Binding properties of biotinylated epidermal growth factor to its receptor on cultured cells and tissue sections. Journal of Cellular Biochemistry. 41(2). 47–56. 5 indexed citations
16.
Spitzer, E., et al.. (1988). EGF binding is quantitatively related to growth in node-positive breast cancer. Breast Cancer Research and Treatment. 12(1). 45–49. 17 indexed citations
17.
Brandt, Ralf, et al.. (1988). A 13-kilodalton protein purified from milk fat globule membranes is closely related to a mammary-derived growth inhibitor. Biochemistry. 27(5). 1420–1425. 46 indexed citations
18.
Müller, Thomas, et al.. (1987). Antibodies against mammary derived growth inhibitor (MDGI) react with a fibroblast growth inhibitor and with heart fatty acid binding protein. Biochemical and Biophysical Research Communications. 148(3). 1425–1431. 36 indexed citations
19.
Grosse, Richard, et al.. (1982). Is the Sarcolemmal Na+ −K+ ATPase Involved in Active Calcium Transport?. PubMed. 3. 335–344. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanny Norris Breakdown of academic impact, for papers by Miho Takahashi Breakdown of academic impact, for papers by Douglas W. Morgan Breakdown of academic impact, for papers by Giovanni Alfredo Puca Breakdown of academic impact, for papers by Roy A. Johanson Breakdown of academic impact, for papers by Jianming Lu Breakdown of academic impact, for papers by Howard C. Haspel Breakdown of academic impact, for papers by John L. Krstenansky Breakdown of academic impact, for papers by Paolo Laccetti Breakdown of academic impact, for papers by K. Nagano
Rankless by CCL
2026